What three mediator antagonists have been reported to be useful in symptomatic control of urticaria? Competitive antagonists of the H1 and H2 histamine receptor and antagonists of leukotriene D4 receptor have been reported to be useful in treating urticaria. The latter two are usually used in conjunction with an H1 antagonist. Recent studies suggest that the nonsedating H1 antagonists are just as effective in treating urticaria as the classic, sedating antagonists. Bensch GW, Borish L: Leukotriene receptor antagonists in the treatment of chronic idiopathic urticaria (abstract), J Allergy Clin Immunol 103:S154, 1999. Monroe EW, Bernstein DI, Fox RW, et al: Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria, Arzneimittelforschung 42:1119–1121, 1992. |
© 2024 Skin Disease & Care | All Rights Reserved.